Welcome, visitor! [ Register | Login

€240.00

Sick And Tired Of Doing Xarelto Lawsuit The Old Way? Read This

  • Street: Kolbergveien 110
  • City: Notteroy
  • State: Arizona
  • Country: Norway
  • Zip/Postal Code: 3121
  • Listed: Март 5, 2017 7:17 пп
  • Expires: This ad has expired

Description

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use — and failure to do so may be grounds for compensation. Our lawyers are functioning challenging to get those hurt by the drug the compensation they may be entitled to.

Even though bleeding is really a frequent complication connected with anticoagulants, it has been alleged that Xarelto is more unsafe than standard blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, sufferers could be at threat for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a loved one suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For more data, get in touch with us these days to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they’re searching for punitive damages, which are normally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto — http://www.traveldescribe.com/?s=Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this page for far more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed click through the next document — http://xareltolawsuit.bitbucket.org/categories/NE/index.html multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Listing ID: 35858bc3a2868a41

Report problem

Processing your request, Please wait....

Leave a Reply